Tech Company Financing Transactions
EBT Medial Funding Round
On 12/5/2019, EBT Medial raised $10 million in Series A financing from Genesys Capital, SV Health Investors and private investors.
Transaction Overview
Company Name
Announced On
12/5/2019
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Genesys Capital (Lead Investor)
SV Health Investors (Lead Investor)
Proceeds Purpose
The company intends to use the funds to: further develop its noninvasive neuromodulation technology, to pursue additional clinical data validating its safety and effectiveness, to expand the management team and for general administrative purposes.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
664 Adams St.
Holliston, MA 01746
USA
Holliston, MA 01746
USA
Phone
Undisclosed
Website
Email Address
Overview
EBT is a venture-backed, clinical stage company pursuing disruptive neuromodulation technologies, focused on pelvic floor disorders. Our first product is a novel, discreet non-invasive neuromodulation therapy & associated ecosystem for patients with overactive bladder, centered on a new target: the Saphenous nerve.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Keith Carlton
Chief Operating Officer
Sasha John
President
Paul Yoo
VP - Marketing
Ken Mariash
VP - R & D
Tamara Baynham
Browse more venture capital transactions:
Prev: 12/5/2019: Thrasio venture capital transaction
Next: 12/5/2019: Nexit venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs